Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Return on Assets (2016 - 2025)

Historic Return on Assets for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to 0.52%.

  • Viridian Therapeutics, Inc.\DE's Return on Assets fell 1400.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 0.44% for FY2024, which is 800.0% up from last year.
  • Viridian Therapeutics, Inc.\DE's Return on Assets amounted to 0.52% in Q3 2025, which was down 1400.0% from 0.55% recorded in Q2 2025.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Return on Assets ranged from a high of 0.3% in Q4 2022 and a low of 1.1% during Q2 2021
  • In the last 5 years, Viridian Therapeutics, Inc.\DE's Return on Assets had a median value of 0.45% in 2022 and averaged 0.53%.
  • As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Return on Assets surged by 9800bps in 2021, and later crashed by -2800bps in 2023.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Return on Assets (Quarter) stood at 0.37% in 2021, then rose by 21bps to 0.3% in 2022, then tumbled by -96bps to 0.58% in 2023, then soared by 39bps to 0.36% in 2024, then plummeted by -46bps to 0.52% in 2025.
  • Its Return on Assets was 0.52% in Q3 2025, compared to 0.55% in Q2 2025 and 0.44% in Q1 2025.